Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Has results × Rhabdomyosarcoma, Alveolar × Clear all

Phase

Phase 1/2 3 Phase NA 1 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 333 Neoplasms 231 Prostatic Neoplasms 164 Lung Neoplasms 119 Colorectal Neoplasms 113 Head and Neck Neoplasms 67 Colonic Neoplasms 57 Carcinoma, Hepatocellular 54 Pancreatic Neoplasms 53 Carcinoma, Non-Small-Cell Lung 52 Uterine Cervical Neoplasms 49 Multiple Myeloma 49 Precursor Cell Lymphoblastic Leukemia-Lymphoma 45 Neoplasm Metastasis 45 Leukemia, Myeloid, Acute 41 Brain Neoplasms 38 Rectal Neoplasms 37 Lymphoma 37 Liver Neoplasms 37 Motor Activity 36 Lymphoma, Non-Hodgkin 36 Leukemia 33 Ovarian Neoplasms 32 Hodgkin Disease 32 Pain 31 Melanoma 31 Fatigue 29 Barrett Esophagus 29 Lymphoma, Follicular 27 Myelodysplastic Syndromes 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01412541 2020-05-12

LEVANT 2

C. R. Bard

Phase NA Completed

532 enrolled 23 charts

Rhabdomyosarcoma, Alveolar

Data powered by HemOnc (CC BY 4.0) Colophon ⚡